FMP

FMP

Enter

SKIN - The Beauty Health Co...

photo-url-https://images.financialmodelingprep.com/symbol/SKIN.png

The Beauty Health Company

SKIN

NASDAQ

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

1.67 USD

-0.14 (-8.38%)

Operating Data

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Revenue

1.6B

760.42M

296.37M

158.69M

88.03M

98.11M

109.33M

121.85M

135.79M

151.33M

Revenue %

-

-52.62

-61.03

-46.45

-44.53

11.45

11.45

11.45

11.45

Ebitda

-39.33M

-8.99M

2.56M

-9.74M

-19.4M

-6.07M

-6.77M

-7.54M

-8.4M

-9.37M

Ebitda %

-2.45

-1.18

0.87

-6.14

-22.04

-6.19

-6.19

-6.19

-6.19

Ebit

-44.73M

-14.05M

-170.64k

-11.18M

-20.54M

-6.88M

-7.67M

-8.55M

-9.52M

-10.61M

Ebit %

-2.79

-1.85

-0.06

-7.05

-23.33

-7.01

-7.01

-7.01

-7.01

Depreciation

5.41M

5.06M

2.74M

1.44M

1.14M

810.06k

902.77k

1.01M

1.12M

1.25M

Depreciation %

0.34

0.67

0.92

0.91

1.29

0.83

0.83

0.83

0.83

Balance Sheet

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Total Cash

227.99M

164.73M

130.25M

86.16M

72.15M

42.4M

47.25M

52.66M

58.68M

65.4M

Total Cash %

14.21

21.66

43.95

54.3

81.96

43.22

43.22

43.22

43.22

Receivables

20.69M

23.73M

16.6M

12.97M

9.03M

5.58M

6.22M

6.93M

7.72M

8.61M

Receivables %

1.29

3.12

5.6

8.17

10.26

5.69

5.69

5.69

5.69

Inventories

58.9M

18.6M

11.62M

7.51M

5.87M

4.21M

4.69M

5.23M

5.82M

6.49M

Inventories %

3.67

2.45

3.92

4.74

6.67

4.29

4.29

4.29

4.29

Payable

102.02M

68.96M

35.04M

19.1M

13.31M

10.67M

11.9M

13.26M

14.77M

16.47M

Payable %

6.36

9.07

11.82

12.04

15.12

10.88

10.88

10.88

10.88

Cap Ex

-3.88M

-11.61M

-11.96M

-12.69M

-1.71M

-3.09M

-3.44M

-3.83M

-4.27M

-4.76M

Cap Ex %

-0.24

-1.53

-4.04

-7.99

-1.94

-3.15

-3.15

-3.15

-3.15

Weighted Average Cost Of Capital

Price

1.74

Beta

Diluted Shares Outstanding

1.97B

Costof Debt

4.43

Tax Rate

After Tax Cost Of Debt

4.43

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

1.99M

Total Equity

3.43B

Total Capital

3.43B

Debt Weighting

0.06

Equity Weighting

99.94

Wacc

6.74

Build Up Free Cash Flow

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Revenue

1.6B

760.42M

296.37M

158.69M

88.03M

98.11M

109.33M

121.85M

135.79M

151.33M

Ebitda

-39.33M

-8.99M

2.56M

-9.74M

-19.4M

-6.07M

-6.77M

-7.54M

-8.4M

-9.37M

Ebit

-44.73M

-14.05M

-170.64k

-11.18M

-20.54M

-6.88M

-7.67M

-8.55M

-9.52M

-10.61M

Tax Rate

-10.09

-10.09

-10.09

-10.09

-10.09

-10.09

-10.09

-10.09

-10.09

-10.09

Ebiat

-39.29M

-19.14M

-107.73k

-13.79M

-22.61M

-6.21M

-6.92M

-7.71M

-8.59M

-9.57M

Depreciation

5.41M

5.06M

2.74M

1.44M

1.14M

810.06k

902.77k

1.01M

1.12M

1.25M

Receivables

20.69M

23.73M

16.6M

12.97M

9.03M

5.58M

6.22M

6.93M

7.72M

8.61M

Inventories

58.9M

18.6M

11.62M

7.51M

5.87M

4.21M

4.69M

5.23M

5.82M

6.49M

Payable

102.02M

68.96M

35.04M

19.1M

13.31M

10.67M

11.9M

13.26M

14.77M

16.47M

Cap Ex

-3.88M

-11.61M

-11.96M

-12.69M

-1.71M

-3.09M

-3.44M

-3.83M

-4.27M

-4.76M

Ufcf

-15.32M

-21.48M

-29.15M

-33.24M

-23.39M

-6M

-9.35M

-10.42M

-11.62M

-12.95M

Wacc

6.74

6.74

6.74

6.74

6.74

Pv Ufcf

-5.62M

-8.21M

-8.57M

-8.95M

-9.34M

Sum Pv Ufcf

-40.69M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

6.74

Free Cash Flow T1

-13.01M

Terminal Value

-208.47M

Present Terminal Value

-150.44M

Intrinsic Value

Enterprise Value

-191.14M

Net Debt

-69.17M

Equity Value

-121.97M

Diluted Shares Outstanding

1.97B

Equity Value Per Share

-0.06

Projected DCF

-0.06187749 29.12%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep